Comparative chemical genomics reveal that the spiroindolone antimalarial KAE609 (Cipargamin) is a P-type ATPase inhibitor

The spiroindolones, a new class of antimalarial medicines discovered in a cellular screen, are rendered less active by mutations in a parasite P-type ATPase, PfATP4. We show here that S. cerevisiae also acquires mutations in a gene encoding a P-type ATPase (ScPMA1) after exposure to spiroindolones a...

Descripción completa

Detalles Bibliográficos
Autores principales: Goldgof, Gregory M., Durrant, Jacob D., Ottilie, Sabine, Vigil, Edgar, Allen, Kenneth E., Gunawan, Felicia, Kostylev, Maxim, Henderson, Kiersten A., Yang, Jennifer, Schenken, Jake, LaMonte, Gregory M., Manary, Micah J., Murao, Ayako, Nachon, Marie, Murray, Rebecca, Prescott, Maximo, McNamara, Case W., Slayman, Carolyn W., Amaro, Rommie E., Suzuki, Yo, Winzeler, Elizabeth A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4904242/
https://www.ncbi.nlm.nih.gov/pubmed/27291296
http://dx.doi.org/10.1038/srep27806

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4904242/
https://www.ncbi.nlm.nih.gov/pubmed/27291296
http://dx.doi.org/10.1038/srep27806

Ejemplares similares